NXTCL
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
NextCell Pharma is a Swedish clinical-stage cell therapy company developing treatments for immune-mediated diseases, with the company's most recent candidate being a type 1 diabetes candidate. The company's platform, NXTCL™, is designed to enable cell therapies with consistent efficacy, scalable manufacturing and the potential to change the course of the disease. NextCell is headquartered in Huddinge.
Lue lisääLiikevaihto milj.
EBIT-% (oik.)
EPS (oik.)
Osinko %
Osavuosikatsaus Q3'26
Vuosikatsaus '26
Osavuosikatsaus Q1'27
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
